Literature DB >> 12429601

Magnetic resonance spectroscopy and cognitive function in healthy elderly men.

Karen J Ferguson1, Alasdair M J MacLullich, Ian Marshall, Ian J Deary, John M Starr, Jonathan R Seckl, Joanna M Wardlaw.   

Abstract

Subtle cognitive decrements in older people are important in terms of the associated morbidity and as a risk factor for dementia. However, their pathophysiological basis is poorly understood. Proton magnetic resonance spectroscopy ((1)H-MRS) may provide the means to investigate early changes in brain metabolite concentrations. We examined the relationships between N-acetylaspartate (NAA), choline (Cho) and creatine (Cr) metabolite ratios in a voxel in the parietal cortex and cognitive function in 88 healthy, non-demented, unmedicated men aged 65-70 years. We also used linear regression to give a value for each metabolite adjusted for the levels of the other two metabolites. Both NAA/Cr and Cho/Cr ratios correlated positively with tests of verbal memory and a verbal memory factor (e.g. NAA/Cr and Logical Memory: r = 0.24, P < 0.05). Cho/Cr ratios also correlated positively with tests of visual memory (e.g. visual reproduction: r = 0.21, P < 0.05). Adjusted Cr levels correlated negatively and significantly with tests of verbal memory and the Verbal Memory Factor. The regression analysis suggested that Cr levels better explained the correlations between NAA/Cr and Cho/Cr ratios and cognitive variables than NAA or Cho levels. These results suggest that in healthy men aged 65-70 years, metabolite levels relate to cognitive performance. Rising Cr levels may be an early marker of cognitive decline.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429601     DOI: 10.1093/brain/awf278

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  30 in total

1.  Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease.

Authors:  Adriane Gröger; Grzegorz Chadzynski; Jana Godau; Daniela Berg; Uwe Klose
Journal:  Eur Radiol       Date:  2011-04-12       Impact factor: 5.315

2.  Cognitive deficits and changes in neurometabolites after a lacunar infarct.

Authors:  M J E van Zandvoort; J van der Grond; L J Kappelle; E H F de Haan
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

3.  Metabolite levels in the brain reward pathway discriminate those who remain abstinent from those who resume hazardous alcohol consumption after treatment for alcohol dependence.

Authors:  Timothy C Durazzo; Varsha Pathak; Stefan Gazdzinski; Anderson Mon; Dieter J Meyerhoff
Journal:  J Stud Alcohol Drugs       Date:  2010-03       Impact factor: 2.582

4.  Beneficial Effects of Yogasanas and Pranayama in limiting the Cognitive decline in Type 2 Diabetes.

Authors:  Santhakumari Rajani; Rajagopalan Archana; Yogananda Reddy Indla; P Rajesh
Journal:  Natl J Physiol Pharm Pharmacol       Date:  2016-09-24

5.  Enlarged perivascular spaces are associated with cognitive function in healthy elderly men.

Authors:  A M J Maclullich; J M Wardlaw; K J Ferguson; J M Starr; J R Seckl; I J Deary
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

6.  Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies.

Authors:  Jonathan Graff-Radford; Bradley F Boeve; Melissa E Murray; Tanis J Ferman; Nirubol Tosakulwong; Timothy G Lesnick; Mandie Maroney-Smith; Matthew L Senjem; Jeffrey Gunter; Glenn E Smith; David S Knopman; Clifford R Jack; Dennis W Dickson; Ronald C Petersen; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2014-01-08       Impact factor: 4.673

7.  New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images.

Authors:  Maria del C Valdés Hernández; Karen J Ferguson; Francesca M Chappell; Joanna M Wardlaw
Journal:  Eur Radiol       Date:  2010-02-16       Impact factor: 5.315

8.  The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.

Authors:  A D Waldman; G S Rai
Journal:  Neuroradiology       Date:  2003-07-22       Impact factor: 2.804

Review 9.  Proton magnetic resonance spectroscopy in alcohol use disorders: a potential new endophenotype?

Authors:  Dieter J Meyerhoff; Timothy C Durazzo
Journal:  Alcohol Clin Exp Res       Date:  2008-07       Impact factor: 3.455

10.  Preliminary study of the association of white-matter metabolite concentrations with disease severity in patients with Huntington's disease.

Authors:  Jeffrey R Yager; Charles Gasparovic; Vincent A Magnotta; William Adams; Jess Fiedorowicz; Jane Paulsen; Ricardo Jorge; Leigh J Beglinger
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.